HIVR4P 2024

HIVR4P 2024
October 06-10, 2024
Lima, Peru & Virtual

HIV Research for Prevention 2024.

Explore more information for Gilead HIV / AIDS therapies
Material Type
Filter by Keyword(s)

Filter results with keywords such as:

  • Name of author(s)
  • Disease state
  • Indication
  • Trial phase
  • Trial name
  • Trial date

Note: Multiple keywords can be applied at the same time.

    Results (2)

    Global racial, ethnic, and gender diversity among participants enrolled in the PURPOSE 2 trial of lenacapavir for pre-exposure prophylaxis

    • Author(s): Gallardo-Cartagena, J
    • lenacapavir
    • HIV / AIDS

    Twice-Yearly Lenacapavir for HIV Prevention in Cisgender Gay, Bisexual, and Other Men, Transgender Women, Transgender Men, and Gender-Nonbinary People who Have Sex With Partners Assigned Male at Birth: Interim Analysis Result from the PURPOSE 2 study

    • Author(s): Kelley, C
    • lenacapavir
    • HIV / AIDS